Yamamoto to speak on intracellular receptors at ASU

Keith Yamamoto will speak about intracellular receptors that regulate steroid and thyroid hormones at 10 a.m., March 27, at ASU's Biodesign Institute.

Attendees will hear the latest findings on how nuclear receptors signal information and regulate gene transcription that control development, cell differentiation, disease and responses to environmental signals and stresses.

“Keith’s findings have pioneered our understanding about how gene expression is regulated,” says Joshua LaBaer, director of the Biodesign Institute’s Virginia G. Piper Center for Personalized Diagnostics. LaBaer and colleague Marco Mangone invited Yamamoto to visit ASU. 

Yamamoto, vice chancellor for research at the University of California-San Francisco (UCSF), executive dean of UCSF’s School of Medicine and professor of cellular and molecular pharmacology, oversees strategic planning and research activities at the school of medicine, and has been a member of UCSF faculty since 1976.

Well regarded among scientific circles, Yamamoto chairs two groups for the National Academy of Sciences: the Coalition for Life Sciences and the Board on Life Sciences. He is an advocate for public and scientific policy, and public understanding and support of biological research and science education. 

His talk, titled “Glucocorticoid Receptor: Regulatory Selectivity, Logic and Allostery,” is part of the Biodesign Discovery Series.

The seminar will take place in the Biodesign Institute auditorium, B-105, just off the lobby of Biodesign Building B, 727 E. Tyler St. Seating is limited, so early arrival is recommended.

The Biodesign Institute tackles global challenges to improve health, protect lives and sustain our planet.